阿萨摩素是一种软菌素衍生物,对MyD88和TRIF依赖的通路具有抑制作用
Yuki Nakajima1, Hitomi Nishino1, Kazunori Takahashi1
1School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Ebara 2-4-41 Shinagawa-Ku, Tokyo, 142-8501, Japan.
Journal of natural medicines
|September 16, 2024
概括
亚萨摩素是一种菌素衍生物,通过阻断MyD88和TRIF等关键信号通路,有效地抑制炎症反应. 这种化合物抑制了免疫细胞中氧化和干扰素β的产生.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 之前已经证明,阿萨摩素 (mollugin的aza衍生物) 抑制了氧化 (NO) 生产.
- 炎症涉及复杂的信号通路,包括那些由托尔类受体 (TLR) 介导的信号通路.
研究的目的:
- 为了研究亚萨摩素抗炎作用背后的分子机制.
- 为了确定阿萨摩素是否针对与先天免疫有关的特定信号通路.
主要方法:
- 利用脂聚糖 (LPS) 刺激的RAW 264.7细胞来评估NO的产生和基因表达.
- 研究了阿萨莫卢金对核因子-卡帕B (NF-κB),干扰素调节因子3 (IRF3) 和托尔类受体 (TLR) 信号通路的影响.
- 研究了关键信号分子的激活和酸化,包括IRAK1,TBK1和IKKε.
主要成果:
- 阿扎莫卢金抑制了由NF-κB调节的诱导性氧化合成酶 (iNOS) 基因表达.
- 阿萨莫卢金抑制了LPS诱导的干扰素β (IFN-β) 表达,由IRF3.3调节.
- 阿萨莫卢金抑制了LPS诱导的IRAK1激活,表明对MyD88依赖途径的影响.
- 阿萨摩素抑制了LPS诱导的IRF3和TBK1/IKKε的酸化,这表明它通过TLR4.4对TRIF依赖途径产生影响.
- 阿萨摩素抑制了TBK1和IRF3的聚I:C诱导的酸化,这表明它通过TLR3.3对TRIF依赖途径产生影响.
结论:
- 阿萨摩素对TLRs激活的MyD88依赖性和TRIF依赖性通路都表现出强大的抑制活性.
- 这些发现突出了阿萨摩素作为一种潜在的治疗剂,通过调节关键的免疫信号级联来治疗炎症性疾病.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K


